Rapibloc 20 mg/2 ml Konzentrat zur Herstellung einer Injektionslösung
Recall
|
Medicines
|
31/03/2022
The marketing authorisation holder informed its customers on March 31, 2022, that the stability data of the mentioned batch has reached the specification limit six months prior the expiry date. For this reason, this batch is recalled as a precaution.
| Name of the medicinal product | Rapibloc 20 mg/2 ml Konzentrat zur Herstellung einer Injektionslösung |
|---|---|
| Marketing authorisation number(s) | 137586 |
| CIP code | 4467284 |
| Marketing authorisation holder | Amomed Pharma GmbH |
| Batch number(s) | LA2101AT |
| Expiry date | 08/31/2022 |
| Classification of the recall | 3 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-3820 |
Further inquiry note
Page last modified:
31/03/2022